RIO-Lipids
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias
Sponsor study identifier
interventional
1,033
8 countries
35
Study Start
September 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2003
Actual (reported)Study Completion
November 2003
Actual (reported)To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2003
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2001
Date type not reportedThis date has not been verified as actual or estimated.
January 23, 2002
Actual (reported)January 24, 2002
Actual (reported)November 2003
Actual (reported)November 2003
Actual (reported)Change from baseline in body weight at 1 year.
Metabolic parameters
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Clinic of Physicians and Surgeons, LTD
Mesa, Arizona, 85201, United States
Arizona Clinical Research Center, Inc.
Tucson, Arizona, 85712, United States
Irvine Center for Clinical Research (ICCR)
Irvine, California, 92618, United States
Los Angeles Clinical Trials
Los Angeles, California, 90064, United States
Apexute
Santa Ana, California, 92705, United States
Clinical Research of South Florida
Coral Gables, Florida, 33134, United States
Radiant Research
Stuart, Florida, 34996, United States
Despres JP, Golay A, Sjostrom L; Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005 Nov 17;353(20):2121-34. doi: 10.1056/NEJMoa044537.
ICD CSD
Sanofi
1,033 participants (actual enrollment reported by the registry).
First Submitted
January 23, 2002
First Posted
January 24, 2002
Study Start
September 2001
Date type not reportedThis date has not been verified as actual or estimated.
Obese Patients With Type 2 Diabetes
Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
nTouch Research
Peoria, Illinois, 61602, United States
nTouch Research
South Bend, Indiana, 46601, United States
Bluegrass Clinical Research, Inc.
Louisville, Kentucky, 40291, United States
Johns Hopkins Women's Research Core
Lutherville, Maryland, 21093, United States
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
Twin Cities Clinical Research
Arden Hills, Minnesota, 55126, United States
Radiant Research
Edina, Minnesota, 55435, United States
Women's Clinic of Lincoln, PC
Lincoln, Nebraska, 68510, United States
New Mexico Clinical Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico, 87106, United States
Clinical Research Services
Bismarck, North Dakota, 58501, United States
University of Cincinnati College of Medicine
Cincinnati, Ohio, 45267-0559, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635, United States
Clinical Research Division
Newtown, Pennsylvania, 18940, United States
Clinical Research Center of Reading, LLC
West Reading, Pennsylvania, 19611-1124, United States
Medical University of South Carolina, Division of Clinical Pharmacology
Charleston, South Carolina, 29425, United States
Nashville Medical Research Institute
Nashville, Tennessee, 37205, United States
Radiant Research
Salt Lake City, Utah, 84111, United States
Clinical Research Center of Northern Virginia
Falls Church, Virginia, 22044, United States
Hunter Holmes McGuire Medical Center Research Service (151)
Richmond, Virginia, 23249, United States
Vancouver Medical Weight Loss Clinic
Vancouver, Washington, 98685, United States
Addiction & Psychiatric Medicine Research
Morgantown, West Virginia, 26506-9300, United States
Sanofi-aventis Administrative Office
Macquarie Park, Australia
Sanofi-aventis Administrative Office
Laval, Canada
Sanofi-aventis Administrative Office
Helsinki, Finland
Sanofi-aventis Administrative Office
Milan, Italy
Sanofi-aventis Administrative Office
Barcelona, Spain
Sanofi-aventis Administrative Office
Bromma, Sweden
Sanofi-aventis Administrative Office
Geneva, Switzerland
Primary Completion
November 2003
Actual (reported)Study Completion
November 2003
Actual (reported)Last Updated
April 20, 2009
Record last verified: 2009-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: